Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015 U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus

Published 2017 View Full Article

Authors

Keywords

Turkey (, Meleagris gallopavo, ), Highly pathogenic avian influenza virus, Vaccine efficacy, Viral shedding, Reverse genetics, Recombinant vaccine

Journal

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY

Volume 191, Issue -, Pages 74-79

Publisher

Elsevier BV

Online

2017-08-11

DOI

10.1016/j.vetimm.2017.08.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started